Tag Index  /  Showing 1 - 5 of 5 results for “Sue Desmond-Hellmann”

Bio & Life Sciences Healthcare Techonomy Events

How Techonomy Bio Inspired My Southeast Asian Healthcare Journey

Last year, I watched the inaugural Techonomy Bio conference from a hotel in Ho Chi Minh City. At the time, I was working on my first healthcare consulting project—a market research study for German medical device manufacturers interested in Vietnam. I spent my days interviewing suppliers, distributors, purchasers, regulators, and other stakeholders, trying to make sense of the snarled Vietnamese healthcare system. Due to the time difference between Vietnam and America, I couldn’t catch the live webcast of the conference, but in the week after the event, I ended each day by kicking up my feet and watching video footage of the 2014 conference sessions on my laptop. Watching those videos hammered home the fact that in both developed and developing countries, much of modern healthcare is fundamentally broken.   More

Bio & Life Sciences Techonomy Events

Meat Without Animals and Sequencing the Planet at Techonomy Bio

The over 200 people who descended on the Computer History Museum in the heart of Silicon Valley last week for the second annual Techonomy Bio event learned we were heading toward growing meat, cell phones, and houses. They learned as well that we are in a renaissance of progress in human health. But they also heard thoughts on why we have more allergies and worries about how the public thinks about science. The daylong program ranged from stem cells and bio-architecture to venture capital and public opinion about science, but the common thread was the intersection of progress in the dual realms of life science and information technology. As speakers noted throughout the day, the intersection of big data and biology has helped create a field ripe for breakthroughs.   More

Bio & Life Sciences Techonomy Events

Marc Benioff and Gates Foundation’s Desmond-Hellmann Agree: Digital Health So Far Is Pitiful

For an onstage conversation at Techonomy Bio 2015 about how science is advancing human progress around the world and where the greatest challenges still remain, Susan Desmond-Hellmann and Marc Benioff might seem an unlikely pair. She’s an oncologist accomplished in biotech, academia, and, now, the nonprofit sector as CEO of the Bill & Melinda Gates Foundation. Benioff is chairman of the customer relationship management software company Salesforce.com. But, as the two agreed here on Wednesday, more crossover between his sector—information technology—and hers—healthcare—are exactly what’s needed for great leaps forward in life sciences.   More

Techonomy Events

Techonomy Bio 2015 Live Webcast

Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new collaborative and open-source thinking, these advances affect everything from manufacturing to medicine, food to fuel and business to buildings. We […]   More

Bio & Life Sciences

Next Week’s Techonomy Bio: A Focus on Systems of Life

At last year's Techonomy Bio, we put venture capitalist Steve Jurvetson on a panel of investors. In his enthusiasm for the unbridled potential of innovation in the life sciences to transform society, Jurvetson at one point said "we're sitting on a can of miracles." Why a can? He did not say, but his observation became a kind of touchstone for us at Techonomy for why we continue to build this event. "Sitting on a Can of Miracles" is what we're calling this year's session on investing in bio-progress. Jurvetson himself we have promoted to our opening panel, which our Director of Programs Alex Cudaback christened "You Say You Want a Revolution?" Here we ask where we'll see the most impact from life sciences innovation, and how information technology is driving bio-progress.   More